ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 178 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $176,000 | -30.4% | 14,129 | -23.5% | 0.00% | -50.0% |
| Q3 2016 | $253,000 | +48.8% | 18,460 | -19.9% | 0.00% | +100.0% |
| Q2 2016 | $170,000 | +20.6% | 23,057 | +4.7% | 0.00% | 0.0% |
| Q1 2016 | $141,000 | +35.6% | 22,030 | +31.8% | 0.00% | 0.0% |
| Q4 2015 | $104,000 | -18.8% | 16,714 | -23.9% | 0.00% | 0.0% |
| Q3 2015 | $128,000 | +124.6% | 21,964 | +217.5% | 0.00% | – |
| Q2 2015 | $57,000 | +29.5% | 6,917 | +28.3% | 0.00% | – |
| Q1 2015 | $44,000 | +18.9% | 5,390 | +0.2% | 0.00% | – |
| Q4 2014 | $37,000 | +5.7% | 5,381 | -15.8% | 0.00% | – |
| Q3 2014 | $35,000 | -14.6% | 6,394 | 0.0% | 0.00% | – |
| Q2 2014 | $41,000 | -28.1% | 6,394 | -9.5% | 0.00% | -100.0% |
| Q1 2014 | $57,000 | +21.3% | 7,068 | +2.2% | 0.00% | – |
| Q4 2013 | $47,000 | -89.3% | 6,917 | -71.0% | 0.00% | -100.0% |
| Q3 2013 | $439,000 | +100.5% | 23,867 | +90.7% | 0.00% | +100.0% |
| Q2 2013 | $219,000 | – | 12,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |